Analyzing the Future of 23andMe: Innovation and Data Assets

This chapter examines the health and prospects of 23andMe, highlighting the company's dual focus on consumer and therapeutic services. It underscores the significance of its data assets and the imperative for ongoing innovation and financial stability in the evolving landscape of genetic health care.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app